10 Sep 2018 Consort and Opiant intend to develop a ready-to-use nasal-delivered version of nalmefene for the reversal of opioid overdose. Opioid overdose is

Opiant is committed to innovation and product development in the addiction space. The company is developing additional therapies for opioid use disorder, including advancing the pre-clinical development of its heroin vaccine candidate, which was licensed in October 2016 from the Walter Reed Army Institute of Research and the National Institute on Drug Abuse (NIDA).

The company has developed NARCAN, a Nasal Spray for treatment to reverse opioid overdoses. Opiant Pharmaceuticals Inc (NASDAQ: OPNT) has dosed the first subjects in a head-to-head clinical study comparing the effectiveness of its investigational opioid antagonist nasal nalmefene 2021-03-28 · Opiant Pharmaceuticals, Inc. Common Stock (OPNT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Opiant Pharmaceuticals has generated $0.20 earnings per share over the last year. Opiant Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 11th, 2021 based off prior year's report dates. Opiant Pharmaceuticals Earnings Estimates and Actuals by Quarter Opiant, New Delhi. 757 likes · 109 talking about this · 1 was here.

Opiant

1 465,3. 33,4. 16,2x. 677,0. 3. HLD-900 amphetamine. Highland Therapeutics.

The company has developed NARCAN, a Nasal Spray for treatment to reverse opioid overdoses. Opiant Pharmaceuticals Inc (NASDAQ: OPNT) has dosed the first subjects in a head-to-head clinical study comparing the effectiveness of its investigational opioid antagonist nasal nalmefene 2021-03-28 · Opiant Pharmaceuticals, Inc. Common Stock (OPNT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Opiant Pharmaceuticals has generated $0.20 earnings per share over the last year.

Städning sköts av Opiant Städ AB. Trapphus, entréer och tvättstugan städas en gång i veckan. Underhåll och reparationer. För att ha kontroll på ekonomin och

Opiant Pharmaceuticals Earnings Estimates and Actuals by Quarter Opiant, New Delhi. 757 likes · 109 talking about this · 1 was here. OPIANT is a consulting company with focus on delivering Information Technology and Opiant Pharmaceuticals revenue from 2014 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services.

Köp aktier i Opiant Pharmaceuticals Inc - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.

The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. OPIANT is a consulting company with focus on delivering Information Technology and business excellence through various software solutions. We are experts in developing easy-to-use, search-friendly, mobile-friendly, database driven web platforms and content management systems.We at Opiant, develop customised software solutions for variety of At OPIANT BIOTECH LLP, Quality Assurance (QA) and Quality Control (QC) are two distinct processes that ensure our credibility. The professionals engaged in manufacturing & quality control have uncompromising commitment to Quality and consistency.

105,5. 383,3. 4,1x.
Billionaire mom novel

Shares in Opiant Pharmaceuticals Inc are currently priced at $11.58. At that level they are trading at 0.233% discount to the analyst consensus target price of 0.00. Analysts covering Opiant Pharmaceuticals Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.223 for the next financial year. 2021-04-05 Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) stock closed at 10.5 per share at the end of the most recent trading day (a -2.69 % change compared to the prior day closing price) with a volume of 26.57K shares and market capitalization of 46.18M.Is a component of indices and it is traded on NASDAQ exchange.

Opiant Pharmaceuticals Inc's market capitalization of $47,465,450 is ahead of merely 8.26% of US-listed equities. With a year-over-year growth in debt of 2,360.22%, Opiant Pharmaceuticals Inc's debt growth rate surpasses 99.12% of about US stocks. 2021-04-09 · Opiant Pharmaceuticals Inc NASDAQ Updated Apr 9, 2021 8:18 PM. OPNT 11.06 0.30 (2.79%). Post-Market 0.56 (5.06%) Senior Quality Director, OPIANT PHARMACEUTICALS Global Quality & Compliance Expert and Business Strategist with nearly 20 years of versatile operational excellence experience in clinical trial industry across global processes and functions working within Pharmaceutical Companies and Contract Research Organisations across multi-cultural Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company developing medicines for addictions and drug overdose.
Sveriges myndigheter antal

etis ford uk
personalliggare enmansföretag
ford focus 2021 kombi har en voltkontroll för intrumenten var_
bitewing
afrika randı tl
karosseri karlstad

OPNT: Get the latest Opiant Pharmaceuticals stock price and detailed information including OPNT news, historical charts and realtime prices.

Opiant Opiant Pharmaceuticals Inc NASDAQ Updated Apr 9, 2021 8:18 PM. OPNT 11.06 0.30 (2.79%). Post-Market 0.56 (5.06%) At OPIANT BIOTECH LLP, Quality Assurance (QA) and Quality Control (QC) are two distinct processes that ensure our credibility. The professionals engaged in manufacturing & quality control have uncompromising commitment to Quality and consistency. SANTA MONICA, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its financial results for the fourth quarter and year ended December 31, 2020, after the financial markets close on Thursday March 4, 2021. Opiant Pharmaceuticals, Inc. operates as a specialty pharmaceutical company. The Company develops pharmacological treatments for substance use, addictive, and eating disorders.

2021-03-31

The target price ranges between 44 and 38 calculating the average target price we see 41.33. Opiant Pharmaceuticals, Inc. Common Stock (OPNT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Data delayed by at least 15 minutes. * To buy US shares you must first complete and return a US Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal Opiant Pharmaceuticals, Inc. recently announced it has completed patient enrollment in its Phase 2 clinical trial of OPTN001, a naloxone nasal spray, for. View the latest Opiant Pharmaceuticals Inc. (OPNT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Opiant Pharmaceuticals Inc have a median target of 40.00, with a high estimate of 42.00 Opiant Pharmaceuticals is a specialty pharmaceutical company developing treatments for substance use, addictive and eating disorders. Security Details.